Elevation Oncology Stock Forum

$Elevation Oncology(ELEV.US)$
NEWS
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Elevation Oncology announces promising preclinical data for its HER3-ADC program, showcasing proof-of-concept results at AACR Annual Meeting 2024. The data demonstrates HER3-dependent cell killing and robust anti-tumor activity in solid tumors with high HER3 expression. The company aims to nominate a development candidate later in 2024.

$Elevation Oncology(ELEV.US)$ If you bought when I said back in March 7 you d9bked your money here today !

$Elevation Oncology(ELEV.US)$$Merrimack Pharmaceuticals(MACK.US)$   Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
MT Newswires· 2 mins ago
Merrimack Pharmaceuticals (MACK) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution.
The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...

$Elevation Oncology(ELEV.US)$ Taking a position here soon !

$Elevation Oncology(ELEV.US)$ Elevation Oncology Announced That It Has Expanded Its Ongoing Phase 1 Clinical Trial Of EO-3021 Outside The United States, Dosing The First Patient In Japan

$Elevation Oncology(ELEV.US)$ let's break that 1.48 !